ArticlePediatric research2026
Maternal vitamin D status modifies the association between GDM and offspring neurodevelopment: a prospective birth cohort study.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntrauterine hyperglycemia is a risk factor for offspring neurodevelopmental delay. While vitamin D is neuroprotective, its role in improving outcomes for the offspring of women with gestational diabetes mellitus (GDM) is unclear.
methodsIn a prospective cohort of 7438 pregnant women, serum 25-hydroxyvitamin D [25(OH)D] was measured at 16-23 weeks. GDM was diagnosed at 24-28 weeks, with simultaneous assessment of insulin resistance (HOMA-IR). Umbilical cord blood C-peptide concentrations were measured at delivery. Offspring neurodevelopment was screened at 5-7, 11-13, and 24-36 months.
resultsGDM was associated with a 26% higher risk of neurodevelopmental delay (HR = 1.26, 95% CI: 1.02, 1.56), along with higher HOMA-IR and cord blood C-peptide. Serum 25(OH)D was negatively associated with HOMA-IR and cord blood C-peptide (P for trend < 0.05). In vitamin D-deficient women (25(OH)D < 50 nmol/L), HOMA-IR correlated with cord C-peptide (r = 0.48, P < 0.001), and GDM increased risks of neurodevelopmental delay (HR = 1.34, 95%CI: 1.05, 1.70) and hyperinsulinemia (HR = 1.39, 95%CI: 1.13, 1.72). These associations were absent in vitamin D-sufficient women.
conclusionsAdequate gestational vitamin D may attenuate the intergenerational transmission of glucose metabolism disorders, thereby reducing neurodevelopmental delay risk in GDM offspring. This protective effect requires validation in randomized trials. IMPACT: This study demonstrates that adequate maternal vitamin D status may protect against gestational diabetes mellitus (GDM)-associated neurodevelopmental delays in offspring, identifying a potentially modifiable prenatal factor. It proposes a novel mechanistic pathway, suggesting vitamin D may attenuate the intergenerational transmission of maternal glucose dysregulation, thereby mitigating fetal hyperinsulinemia and subsequent neurodevelopmental risk. The findings support integrating vitamin D assessment and optimization into prenatal care for women with GDM, offering a nutritional strategy for promoting offspring neurodevelopment.
Identifiers
42543385What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.